Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Determine which IRA is best for low-cost index funds to minimize fees and maximize long-term growth across portfolios.
27,103 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
As tariffs re-emerge under Section 301, policymakers push a framework that has endured decades of legal challenges. T...
Macy’s posts a stronger-than-expected Q4, lifting shares in a downbeat retail environment. The company leans into cre...
A NOVA-based startup is turning years of real‑world chaos into hours of simulated mayhem to stress‑test critical syst...
MISMO and ALTA unveiled two datasets in candidate recommendation status to digitize ALTA title and settlement data, s...
Super Micro Computer beat expectations on adjusted earnings and guided higher for Q4 revenue, while unveiling a nucle...
Oil sits near the $100 mark on May 7, 2026, with Brent at 100.45 per barrel at 8:45 a.m. ET. The day’s move echoes br...
BTIG raises its CrowdStrike price target to $621 from $499, signaling strong momentum in platform consolidation among...
Independent single-family rental owners are largely insulated from institutional competition, according to TurboTenan...
SpaceX plans a June IPO that would place a second Musk-led company in the public eye, raising questions about how muc...
A landmark ruling would change who pays tariff costs and could lift earnings for U.S. companies. Markets react as inv...
SpaceX signals a shorter-term AI compute arrangement with Anthropic, shifting away from multi-year plans and promptin...